TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Kaoru Kubota et al.PubMed ↗Publisher ↗

No numbers read from the abstract.